Literature DB >> 10681389

Effect of fixation and epitope retrieval on BrdU indices in mammary carcinomas.

J N McGinley1, K K Knott, H J Thompson.   

Abstract

Studies in which 5-bromo-2'-deoxyuridine (BrdU) is used to quantify rates of cell proliferation are conducted prospectively. Therefore, the opportunity exists to select conditions that optimize detection of the BrdU epitope. The objective of this study was to quantify the extent to which the BrdU epitope was masked by formalin vs methacarn fixation in the assessment of cell proliferation. Mammary carcinomas from animals pulse-labeled with BrdU were trisected. A portion was frozen and the remaining two portions were fixed in 10% neutral buffered formalin or methacarn for 24 hr, processed, embedded in paraffin, and sections stained for incorporated BrdU using a peroxidase immunohistochemical staining technique. Antigen retrieval techniques also were applied to formalin-fixed sections. Fixation in methacarn gave the highest labeling index (16.4%), which was comparable to that observed in unfixed frozen sections (17.5%). Formalin fixation alone dramatically suppressed the labeling index (0.3%), which was only partially recovered using various antigen retrieval techniques (2.1-8.1%). Methacarn fixation is recommended for prospective studies in which BrdU detection is planned because of the quantitative recovery of epitope and the simplicity of the approach.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10681389     DOI: 10.1177/002215540004800305

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  12 in total

1.  Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions.

Authors:  C R Madden; M J Finegold; B L Slagle
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Identification of DNA-synthesizing bacterial cells in coastal North Sea plankton.

Authors:  Annelie Pernthaler; Jakob Pernthaler; Martha Schattenhofer; Rudolf Amann
Journal:  Appl Environ Microbiol       Date:  2002-11       Impact factor: 4.792

Review 3.  Rat models of premalignant breast disease.

Authors:  H J Thompson; M Singh
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

4.  In vivo molecular mediators of cancer growth suppression and apoptosis by selenium in mammary and prostate models: lack of involvement of gadd genes.

Authors:  Weiqin Jiang; Cheng Jiang; Hongying Pei; Lei Wang; Jinhui Zhang; Hongbo Hu; Junxuan Lü
Journal:  Mol Cancer Ther       Date:  2009-03-10       Impact factor: 6.261

5.  Cancer chemopreventive potential of volatile oil from black cumin seeds, Nigella sativa L., in a rat multi-organ carcinogenesis bioassay.

Authors:  Elsayed I Salim
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

6.  Energetics and mammary carcinogenesis: effects of moderate-intensity running and energy intake on cellular processes and molecular mechanisms in rats.

Authors:  Zongjian Zhu; Weiqin Jiang; John N McGinley; Henry J Thompson
Journal:  J Appl Physiol (1985)       Date:  2008-12-18

7.  Long- but not short-term adult-onset, isolated GH deficiency in male mice leads to deterioration of β-cell function, which cannot be accounted for by changes in β-cell mass.

Authors:  Jose Cordoba-Chacon; Manuel D Gahete; Naveen K Pokala; David Geldermann; Maria Alba; Roberto Salvatori; Raul M Luque; Rhonda D Kineman
Journal:  Endocrinology       Date:  2013-12-16       Impact factor: 4.736

8.  Reduced susceptibility to azoxymethane-induced aberrant crypt foci formation and colon cancer in growth hormone deficient rats.

Authors:  Robert E Carroll; Robert A Goodlad; Aleksandra J Poole; Angela L Tyner; R Brooks Robey; Steven M Swanson; Terry G Unterman
Journal:  Growth Horm IGF Res       Date:  2009-04-29       Impact factor: 2.372

9.  Histological assessment of cellular half-life in tissues in vivo.

Authors:  Reinhold G Erben; Kathrin I Odörfer; Michael Siebenhütter; Karin Weber; Sonja Rohleder
Journal:  Histochem Cell Biol       Date:  2008-07-11       Impact factor: 4.304

10.  Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.

Authors:  Raul M Luque; Beatriz S Soares; Xiao-ding Peng; Sonia Krishnan; Jose Cordoba-Chacon; Lawrence A Frohman; Rhonda D Kineman
Journal:  Endocrinology       Date:  2009-04-02       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.